Pharmacokinetic Study of the Use of Nefopam 30 mg Tablets in Patients Suffering From Acute Pain in Rheumatology

Nefopam is a non-opioid analgesic approved for the symptomatic treatment of acute pain, particularly postoperative pain. The HAS has authorized nefopam tablet, while emphasizing the lack of bibliographic data on both the pharmacokinetic and clinical aspects. The aim of this study is to evaluate the pharmacokinetics of nefopam tablets.

NCT Number	NCT07491393
Lead Sponsor	University Hospital, Rouen
Conditions	Acute Rheumatic Pain
Enrollment	24 participants
Start Date	2026-04-01
Primary Completion	2027-04-07 (estimated)
Study Completion	2027-04-07 (estimated)
Updated on ClinicalTrials.gov	2026-03-24